EUVIMEDEUVIMED entdecken
Multizentrische Studie

Transcatheter Aortic Valve‐in‐Valve Implantation for Failing Stentless Bioprosthetic Aortic Valves: An International Multicentre Retrospective Analysis

Clare Rayner iD, Sarang Paleri, Arri Satpal, Daijiro Tomii iD, Thomas Pilgrim, Pablo Codner, Ran Kornowski iD, Antonio Mangieri iD, Francesco Tartaglia iD, Victor Mauri, Ole De Backer iD, Yusuke Kobari und 7 weitere

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70376 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Clare Rayner und 18 weiteren Autor:innen. Beteiligte Einrichtung: Royal Hobart Hospital, Hobart, Tasmania, Australia. Hauptthemen laut MEDLINE: Bioprosthesis, Heart Valve Prosthesis, Prosthesis Failure, Transcatheter Aortic Valve Replacement. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Valve‐in‐valve aortic valve implantation (ViV‐TAVI) offers a less invasive treatment option for patients with a failing surgical bioprosthesis, avoiding the need for redo surgery. ViV‐TAVI within a stentless bioprosthetic valve poses unique technical challenges. We report an international, multicentre experience evaluating procedural and clinical outcomes for patients undergoing ViV‐TAVI for failed stentless bioprosthetic aortic valves.

Aims

To evaluate the procedural feasibility, safety, and clinical outcomes of ViV‐TAVI performed for failed stentless bioprosthetic aortic valves in an international, multicentre cohort.

Methods

We retrospectively analysed 65 patients who underwent ViV‐TAVI for stentless valve failure between 2010 and 2024. Outcome endpoints were based on the Valve Academic Research Consortium 3 (VARC‐3) criteria.

Results

Sixty‐five patients (mean age 78.8 ± 10.2 years; 66.1% male; mean STS‐PROM 6.9 ± 4.7) were included. The mean interval between surgical valve implantation and failure was 12.9 ± 4.1 years, with regurgitation the predominant mechanism of valve dysfunction (52.3%). Procedural success was achieved in 92.3%. 17 patients (26.2%) had upfront coronary protection. Despite this, six patients required unplanned percutaneous coronary intervention (PCI) for coronary obstruction. The 30‐day and 1‐year mortality rate was 0% and 8% respectively.

Conclusions

ViV‐TAVI was an effective intervention for patients with failing stentless bioprosthetic valves, with high procedural success rates despite unique technical challenges. Careful preprocedural imaging, planning, and implementation of coronary protection strategies are critical for optimal patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioprosthesisHeart Valve ProsthesisProsthesis FailureTranscatheter Aortic Valve ReplacementAortic ValveHeart Valve Prosthesis ImplantationAortic Valve InsufficiencyAortic Valve StenosisHumansRetrospective StudiesMaleFemaleAgedProsthesis DesignAged, 80 and overTime FactorsRisk FactorsFeasibility StudiesTreatment Outcome

Stichwörter der Autor:innen

TAVIaortic stenosiscoronary obstructionstentless bioprosthesisvalve‐in‐valve

Autor:innen und Institutionen

  • Royal Hobart Hospital, Hobart, Tasmania, Australia.
  • Victorian Heart Hospital, Clayton, Victoria, Australia.
  • St Thomas Hospital, London, UK.
  • Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Rabin Medical Center, Petah Tikva, Israel.
  • Humanitas Research Hospital Milan, Rozzano, Milan, Italy.

ORCID-Profile: Clare Rayner, Daijiro Tomii, Ran Kornowski, Antonio Mangieri, Francesco Tartaglia, Ole De Backer, Mariama Akodad

Zitieren

APA

Rayner, C., Paleri, S., Satpal, A., Tomii, D., Pilgrim, T., Codner, P., Kornowski, R., Mangieri, A., Tartaglia, F., Mauri, V., De Backer, O., Kobari, Y., Nombela-Franco, L., Ielasi, A., Akodad, M., Sava, R., Patterson, T., Redwood, S., & Adams, H. (2026). Transcatheter Aortic Valve‐in‐Valve Implantation for Failing Stentless Bioprosthetic Aortic Valves: An International Multicentre Retrospective Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70376

Vancouver

Rayner C, Paleri S, Satpal A, Tomii D, Pilgrim T, Codner P, et al. Transcatheter Aortic Valve‐in‐Valve Implantation for Failing Stentless Bioprosthetic Aortic Valves: An International Multicentre Retrospective Analysis. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70376

BibTeX
@article{Rayner2026,
  author = {Rayner, Clare and Paleri, Sarang and Satpal, Arri and Tomii, Daijiro and Pilgrim, Thomas and Codner, Pablo and Kornowski, Ran and Mangieri, Antonio and Tartaglia, Francesco and Mauri, Victor and De Backer, Ole and Kobari, Yusuke and Nombela-Franco, Luis and Ielasi, Alfonso and Akodad, Mariama and Sava, Ruxandra and Patterson, Tiffany and Redwood, Simon and Adams, Heath},
  title = {Transcatheter Aortic Valve‐in‐Valve Implantation for Failing Stentless Bioprosthetic Aortic Valves: An International Multicentre Retrospective Analysis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70376}
}
Kostenlos starten →